Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vatsala N Brahmbhatt"'
Autor:
Jennifer A MacDiarmid, Veronika Langova, Dale Bailey, Scott T Pattison, Stacey L Pattison, Neil Christensen, Luke R Armstrong, Vatsala N Brahmbhatt, Katarzyna Smolarczyk, Matthew T Harrison, Marylia Costa, Nancy B Mugridge, Ilya Sedliarou, Nicholas A Grimes, Debra L Kiss, Bruce Stillman, Christine L Hann, Gary L Gallia, Robert M Graham, Himanshu Brahmbhatt
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0151832 (2016)
Cytotoxic chemotherapy can be very effective for the treatment of cancer but toxicity on normal tissues often limits patient tolerance and often causes long-term adverse effects. The objective of this study was to assist in the preclinical developmen
Externí odkaz:
https://doaj.org/article/e116e1cea4c448e58b0ddb5f6f713be5
Autor:
Stacey L. Pattison, Veronika Langova, Marylia Costa, Himanshu Brahmbhatt, Matthew T. Harrison, Nancy Mugridge, Gary L. Gallia, Katarzyna Smolarczyk, Dale L. Bailey, Luke R. Armstrong, Bruce Stillman, Scott T. Pattison, Vatsala N. Brahmbhatt, Christine L. Hann, Robert M. Graham, Ilya Sedliarou, Jennifer A. MacDiarmid, Neil Christensen, Nicholas A. Grimes, Debra L. Kiss
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0151832 (2016)
PLoS ONE
PLoS ONE
Background Cytotoxic chemotherapy can be very effective for the treatment of cancer but toxicity on normal tissues often limits patient tolerance and often causes long-term adverse effects. The objective of this study was to assist in the preclinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b323ce6a85c048f11561910eefa8336
http://europepmc.org/articles/PMC4822833?pdf=render
http://europepmc.org/articles/PMC4822833?pdf=render
Autor:
Nancy B. Amaro-Mugridge, Scott T. Pattison, Jocelyn Madrid-Weiss, Leo Phillips, Robert M. Graham, Bruce Stillman, Himanshu Brahmbhatt, Carlotta Petti, Stefanie Wetzel, Ilya Sedliarou, Kartini Kochar, Jennifer A. MacDiarmid, Vatsala N. Brahmbhatt
Publikováno v:
Nature biotechnology. 27(7)
The dose-limiting toxicity of chemotherapeutics, heterogeneity and drug resistance of cancer cells, and difficulties of targeted delivery to tumors all pose daunting challenges to effective cancer therapy. We report that small interfering RNA (siRNA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a375ffb57fbc658ec634887caef5ce
https://pubmed.ncbi.nlm.nih.gov/19587665
https://pubmed.ncbi.nlm.nih.gov/19587665